The World Health Organization concludes there is “limited evidence” in both humans and laboratory animals for the carcinogenicity of radiofrequency radiation, especially from cell phones.
The International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) published its long-awaited monograph on the cancer risk to humans from exposure to cell phone radiation and other radiofrequency electromagnetic fields. The primary focus of the review is on the microwave radiation emitted by cell phones.
Following are what I consider to be the most important quotes from the monograph. I highlighted some phrases with boldface type.
"The term ‘carcinogenic risk’ in the IARC Monographs series is taken to mean that an agent is capable of causing cancer...identification of cancer sites with sufficient evidence or limited evidence in humans should not be viewed as precluding the possibility that an agent may cause cancer at other sites. The evaluations of carcinogenic risk are made by international working groups of independent scientists and are qualitative in nature. No recommendation is given for regulation or legislation.”
“While the number of mobile-phone subscriptions has been increasing rapidly around the world (4.6 billion subscribers in 2009), changes in mobile-phone technology have led to lower time-averaged RF power emitted from mobile phones used at present than those of previous generations. Of major interest to this Monograph is the exposure scenario in which mobile phones are held against the ear during a voice call.” (p. 407)
“GSM 900/1800/PCS phones (Global System for Mobile communications/Personal Communications Service, operating at 900 or 1800 MHz) held next to the ear induce high spatial-averaged SAR values in the brain. This is because adaptive power control on average only reduces the output power to about 50% of its maximum during calls, but this would vary depending on the network software.” (p. 408) [SAR or Specific Absorption Rate is a measure of the maximum amount of radiation absorbed in the brain from a cell phone or cordless phone, averaged over a specific volume of tissue for a specific period of time.]
“Adaptive power control is much more effective with third-generation (3G) phone technologies, and this has led to a reduction of SAR in the brain by almost two orders of magnitude compared with that from GSM phones. The DECT (Digital Enhanced Cordless Telecommunications) phone is another widely used device that is held against the ear to make and receive voice calls. The average SAR in the brain from use of DECT phones is around five times lower than that measured for GSM phones … The spatial maximum exposure from cordless DECT phones is an order of a magnitude lower than that from mobile phones.” (p. 408) [DECT phone technology is used in cordless phones used in homes and offices.]
“Due to the closer proximity of the phone to the brain of children compared with adults, the average exposure from use of the same mobile phone is higher by a factor of 2 in a child’s brain and higher by a factor of 10 in the bone marrow of the skull.” (p. 408)
“In terms of cumulative call time, all odds ratios were uniformly below unity for all deciles of exposure except for the highest decile (≥ 1640 hours of cumulative call time). For this exposure group, the odds ratio for glioma was 1.40 (95% CI, 1.03–1.89). Some other analyses of the same data also pointed to a possible association of mobile-phone use with risk of glioma, including the findings related to location of tumour (a higher odds ratio for tumours in the temporal lobe) and laterality of mobile-phone use (an apparently higher odds ratio in those who used a mobile phone on the same side of the head as the tumour). In an attempt to obviate the distortions that might have been generated by differential non-participation, an analysis was conducted with the lowest exposure decile as the reference; this showed a high odds ratio in the highest exposure decile.” (p. 411)
“In summary, in the INTERPHONE study there was no increased risk of glioma associated with having ever been a regular user of mobile phones. However, there were indications of an increased risk of glioma at the highest levels of cumulative call time, for ipsilateral exposures, and for tumours in the temporal lobe, but chance or bias may explain this increased risk.” (p. 411)
“When mobile phone users were compared with people who reported no use of mobile or cordless phones, or exposure > 1 year before the reference date, an increased odds ratio was estimated (OR, 1.3; 95% CI, 1.1–1.6). The odds ratios increased progressively with increasing time since first mobile phone use, and with increasing cumulative call time for the ordered categories of exposure duration (1–1000, 1001–2000, and > 2000 hours) as follows: 1.2 (95% CI, 0.98–1.4), 1.5 (95% CI, 1.1–2.1), and 2.5 (95% CI, 1.8–3.5), respectively. Ipsilateral use of the mobile phone was associated with higher risk. Further, there were similar findings in relation to the use of cordless phones.” (p. 411)
“Overall, the Working Group reviewed all the available evidence with regard to the use of wireless phones, including both mobile and cordless phones, and the risk of glioma. Time trends were considered, as were several early case–control studies and one cohort study. The evidence from these studies was considered less informative than the results of the INTERPHONE study and the Swedish case–control study. While both of these are susceptible to bias, the Working Group concluded that these findings could not be dismissed as reflecting bias alone, and that a causal interpretation was possible.”
“In considering the evidence on acoustic neuroma, the Working Group considered the same methodological concerns as for glioma, but concluded that bias was not sufficient to explain the positive findings, particularly those of the study from Sweden.” (p. 412) [My note: positive findings refers to increased tumor risk]
“For meningioma, the same two studies mentioned above provided the key evidence. Overall, in each, the findings generally indicated no increase in risk.” (p. 412)
“The Working Group found the evidence to be insufficient to reach a conclusion as to the potential association of mobile-phone use and either leukaemia or lymphoma.” (p. 412)
“Evidence to date does not point to a causal association of mobile-phone use with the various additional malignancies addressed, including ocular or cutaneous melanoma, cancer of the testis, cancer of the breast, or tumours of the parotid gland.” (p. 412)Cancer in Humans
“There is limited evidence in humans for the carcinogenicity of radiofrequency radiation. Positive associations have been observed between exposure to radiofrequency radiation from wireless phones and glioma, and acoustic neuroma.” (p. 421)
“There is limited evidence in experimental animals for the carcinogenicity of radiofrequency radiation.” (p. 412)
“Radiofrequency electromagnetic fields are possibly carcinogenic to humans (Group 2B).” (p. 421)
“The comparative weakness of the associations in the INTERPHONE study and inconsistencies between its results and those of the Swedish study led to the evaluation of limited evidence for glioma and acoustic neuroma, as decided by the majority of the members of the Working Group. A small, recently published Japanese case–control study, which also observed an association of acoustic neuroma with mobile phone use, contributed to the evaluation of limited evidence for acoustic neuroma.” (p. 421)
Non-ionizing radiation, Part II: Radiofrequency electromagnetic fields / IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2011: Lyon, France). Vol. 102 (2013).
The complete monograph can be downloaded from the IARC web site: